EPRG EPR quarterly earnings release arrives management to outline fullyear strategic priorities on investor call CO2 Energy NOEMR Stock Downside Risk Evaluation PCSA Processa Pharmaceuticals posts worsethanexpected Q4 2025 EPS results that miss estimates by 68 percent as shares edge 033 percent lower